Docoh
Loading...

Invus Financial Advisors

Filed: 14 May 20, 12:40pm

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number:3235-0006
Expires:Oct 31, 2018
Estimated average burden
hours per response:23.8

COLUMN 1COLUMN 2COLUMN 3COLUMN 4COLUMN 5COLUMN 6COLUMN 7COLUMN 8
VALUESHRS ORSH/PUT/INVESTMENTOTHERVOTING AUTHORITY
NAME OF ISSUERTITLE OF CLASSCUSIP(x$1000)PRN AMTPRNCALLDISCRETIONMANAGERSOLESHAREDNONE
Alibaba Group Hldg LtdSPONSORED ADS01609W1022361,211SH SOLE 1,21100
Arcus Biosciences IncCOM03969F10925,5681,842,077SH SOLE 1,842,07700
Chegg IncCOM1630921093539,868SH SOLE 9,86800
Novocure LtdORD SHSG6674U10831,709470,884SH SOLE 470,88400
Oyster Point Pharma IncCOM69242L10690,6512,590,015SH SOLE 2,590,01500
Sunrun IncCOM86771W10521921,657SH SOLE 21,65700
Unity Biotechnology IncCOM91381U10112,7022,189,998SH SOLE 2,189,99800
Yext IncCOM98585N10642,2564,146,784SH SOLE 4,146,78400